INSIGHTS ON DRUG DEVELOPMENT
-
3 Key Considerations In Gene Therapy Manufacturing
Viral vector-based gene therapies are redefining medicine. As developers navigate uncharted territory, Sybil Danby of Cytiva highlights three critical areas shaping the journey from discovery to patient access.
-
Outlining The Trends And Challenges In The Inhaled Drug Delivery Market
Explore the latest trends and solutions in inhaled drug delivery, with a focus on overcoming dry powder formulation challenges to advance next-generation therapeutics.
-
Automation Of 3D Intestinal Organoids Culture
Gain insight into how 3D organoids promise better disease modeling and drug screening and how challenges like assay complexity, reproducibility, and scalability hinder their widespread adoption in drug discovery.
-
Accelerate FDA Approval With Fast Track Designation
Learn how Fast Track Designation streamlines the FDA review process and offers faster approval for serious diseases or life-threatening conditions.
-
EMA Support For Rare Disease Therapies6/10/2025
Review how the EMA supports rare disease drug development through regulatory and financial incentives for therapies that meet strict eligibility and ongoing compliance criteria.
-
Epigenetics Application Guide10/2/2024
To fully understand biology and disease mechanisms, it is crucial to explore the role of epigenetic factors. Explore how epigenetic regulation works and methods to study these essential components.
-
Remote Measurements For Bulk Samples12/29/2025
Remote Raman spectroscopy enables accurate material identification at long distances without complex focusing. Learn how pathlength, sample properties, and substrate choice impact signal quality.
-
Utilizing The Colon Intestine-Chip To Investigate Mechanisms Of Gastrointestinal Disease8/2/2024
What are the application and benefits of Organ-Chips and what makes them superior to organoids in the study of GI-related diseases?
-
The Global Leader In Organ-On-A-Chip Technology8/2/2024
What are organ chips, and how are they being used to better predict the human body's response to medications, food, and chemicals?
DRUG DEVELOPMENT SOLUTIONS
-
This device is designed for use with a wide range of drug therapies that require variable dosing.
-
ÄKTA ready™ 450 system is a single-use liquid chromatography system.
-
AST’s line of table-top machines, GENiSYS® Lab, are ideal systems for drug product development and cGMP production applications. Each system is designed to automate the critical aseptic operations for vial, syringe and cartridge processing to reduce contamination risk and product variability. These table-top systems are engineered to have complete compatibility with cleanroom environments, including Laminar Air Flow Hoods, Bio-Safety Cabinets and aseptic isolators.
-
Explore an expansion service with experts that will work closely with you to customize your process and meet your unique needs by adjusting protocols, optimizing conditions, and providing personalized support.
-
Enhance your research and obtain exceptional imaging and analysis with a configurable and upgradeable high-content screening system that captures high-definition images and robust data from 2D and 3D assays.